We are live on ! Find out more
MXCT icon

MaxCyte

112 hedge funds and large institutions have $111M invested in MaxCyte in 2025 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 41 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.33% less ownership

Funds ownership: 67.06%65.73% (-1.3%)

7% less funds holding

Funds holding: 120112 (-8)

22% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 41

29% less capital invested

Capital invested by funds: $156M → $111M (-$45M)

29% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 24

Holders
112
Holders Change
-8
Holders Change %
-6.67%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
17
Increased
32
Reduced
41
Closed
24
Calls
$10K
Puts
Net Calls
+$10K
Net Calls Change
+$10K
Name Holding Trade Value Shares
Change
Change in
Stake
MHC
126
May Hill Capital
Massachusetts
-$27K -12,382 Closed
ZIM
127
Zacks Investment Management
Illinois
-$26.1K -11,976 Closed
RS
128
R Squared
Hong Kong
-$22.5K -10,300 Closed
RI
129
Ridgewood Investments
New Jersey
-$2.18K -1,000 Closed
FFO
130
Fortitude Family Office
Arizona
-$1.51K -693 Closed
Bank of Montreal
131
Bank of Montreal
Ontario, Canada
-$238K -341 Closed
Raymond James Financial
132
Raymond James Financial
Florida
-$661 -303 Closed
Simplex Trading
133
Simplex Trading
Illinois
-$174 -100 Closed
AF
134
Allworth Financial
California
-$155 -71 Closed

MXCT Hedge Fund Activity: Q3 2025 in Review

112 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q3 2025, worth a combined $111M — down 29% from $156M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of MXCT and 17 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 32 added.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $3.66M. The largest seller was Axa, exiting entirely with an estimated $4.8M sold.

  • 112 institutional investors held MaxCyte (MXCT) as of Q3 2025, down from 120 in Q2 2025.
  • Funds reported $111M of MaxCyte stock for Q3 2025, down 29% quarter-over-quarter.
  • 17 funds opened new MaxCyte positions in Q3 2025 and 24 closed out, a net change of -7 holders.
  • The largest MaxCyte buyer in Q3 2025 was Kennedy Capital Management, an estimated $3.66M added.
  • The largest MaxCyte seller in Q3 2025 was Axa, an estimated $4.8M sold.

Based on aggregated 13F filings for Q3 2025.